Atomwise

Atomwise is an AI drug discovery company that uses deep learning-based virtual screening to predict how small molecules will bind to protein targets, dramatically accelerating the hit-finding stage of drug development. The company's AtomNet platform has been trained on millions of experimental binding affinity measurements and can screen billions of compounds computationally to identify promising candidates in days rather than months. Atomwise has collaborated with over 750 research teams acr...

Threads